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Nowadays, many developed nations have aging population which has led to an 
up growth of demand of artificial joints prostheses. With the increasing needs of 
bone implants, the academic community is focusing on improving the mechanical 
and biological properties of implants.  
Bone is mainly composed by hydroxyapatite, and that is the reason why 
hydroxyapatite is known as a stable material for coating orthopaedic implants 
surface. Hydroxyapatite provides an excellent biocompatibility to the implant and 
enhances osseointegration. However, once the use of Hap has extended, some 
limitations and complications have arisen such as low biological interaction. 
Modifying hydroxyapatite by ionic substitution, in order to resemble compositions 
of hydroxyapatite and bone, has emerged as a solution. 
The ionic substitution influences all the properties of synthetic hydroxyapatites. 
In particular, in this project, the ionic substitution of hydroxyapatite has been 
achieved by two strategies. Sol-gel methodology, which the substitution is 
achieved by addition of elements during the synthesis of hydroxyapatite. And, 
ball-milling, where the substitution is done after the synthesis using mechanical 
milling to induce ionic substitution.  
In this bachelor thesis, the study has been focused on synthetizing strontium, 
magnesium and zinc tri-substituted hydroxyapatite with both methods. Moreover, 
a proper characterization of samples has been conducted in order to study the 
effect of ion substitution on its structure. Furthermore, cytotoxicity assays of 
samples obtained against cells have been performed with the aim of studying 
whether they were toxic.  
On the other hand, this project gives an insight into several fields that surround 
the proposed solution, such as the background and state of art of the 
hydroxyapatite synthetize and coating methods, as well as the current market 
situation and regulations of this material. Moreover, the economic feasibility of 
the project it has also been studied.  
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Nowadays, many developed nations have aging population as a result of life 
expectancy has grown over last decades. This huge amount of elderly people 
has led to an up growth of the demand of artificial joints prostheses and dental 
implants.  
An implant is a medical device manufactured to replace a missing biological 
structure and to support or enhance a damaged organ or tissue. Implants are 
made of biomaterials, which can be polymeric, ceramic or metallic such as 
titanium. The academic community is now focusing on improving the mechanical 
and functional properties of these biomaterials [1]. 
Metallic implants are commonly used in orthopaedic and dental industry. Titanium 
alloys are widely used on this field due to its interesting properties such as their 
excellent mechanical strength, biocompatibility (usually defined as the ability of a 
material to perform with an appropriate host response depending on its 
application) and anticorrosion property [2].  
Moreover, titanium alloys spontaneously form a coherent and protective oxide 
layer (TiO₂) of few nanometers thick on its surface providing an excellent 
corrosion resistance and improving its bioactivity [3].  
Although titanium alloys have great properties, sometimes the oxide layer formed 
has not the appropriate thickness or roughness, resulting in a lack of bioactivity 
of the implant and a lower interaction between the prosthesis and the bone, which 
may induce several complications, such as fibrous encapsulation and finally with 
the implant rejection. 
Fibrous encapsulation is the formation of scar tissue on the surface of the implant 
produced by fibrocytes [4]. The formation of this tissue prevents the direct contact 
between the implant and the bone, and this can cause a poor osseointegration. 
Osseointegration is the direct structural and functional connection between living 
bone and the surface of the implant [5]. The implant must have the ability to bond 
with the surrounding tissue. An insufficient osseointegration can result in implant 
failure [6]. 
Researchers have proved that the mechanical properties of the implant and its 
biological interaction between the metal surface and human body are two factors 
which affect the implant’s osseointegration and biocompatibility [7]. 
The surface of an implant plays a critical role in osseointegration, as it is the part 
which is in constant contact with bone and body. Properties of the implant’s 
surface, such as roughness or chemical composition, will determine the quantity 
and quality of bone formation around the implant [2]. Therefore, the improvement 
and modification of Ti-based surface has become an interesting solution by which 
the osseointegration of the implant can be enhanced and the failure implant rates 
can be reduced. 
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There are different methods that by modifying the surface of the implant, an 
improvement in osseointegration, and consequently, a better viability of the 
implant can be achieved.  
One possible strategy to enhance osseointegration is increasing surface 
roughness, which has been evidenced an improvement in cell adhesion and 
proliferation [7]. Another method, such as anodization emerged as a possible 
technique in order to modify implants surfaces. In this process, oxide films are 
deposited on the surface of the implant, achieving a uniform bioactive ceramic 
layer which improves the adhesion of cells [8]. 
However, the surface modification of titanium alloys with Hydroxyapatite (Hap) 
coatings is the most used solution in order to enhance osseointegration. Hap is 
a bio-ceramic material with a chemical composition Ca₁₀(PO₄)₆(OH)₂.The use of 
hydroxyapatite has widely extended due to its chemical similarity content with 
bones.  
Bones are hard tissues which plays a very important role in mobility and stability. 
Those tissues are made of apatite, which is the name of a group of calcium 
phosphate materials. Hydroxyapatite, which is an apatite type, is the major 
component of bone and tooth enamel.  
Beyond the several applications that Hap can have, the main use of Hap is its 
use for coating the surface implant with the aim of stimulate bone healing and 
improving osseointegration [7].  
There are several reasons for coating implants with hydroxyapatite. Firstly, the 
use of HA-coated implants has been reported to stimulate bone healing, resulting 
in improvement of rate initial implant integration. Moreover, the layer of HA on the 
top of the implant enhance stability. The use of HA-coated implants reduce 
recovery time and speed rehabilitation [9]. 
Once the use of Hap coatings on implants has been extended, some limitations 
and complications have arisen such as slow rate of biological interaction, due to 
the high stability of hydroxyapatite structure. Scientists demonstrated that such 
complication may be associated with the composition differences between 
synthetized 
 and natural apatite’s. Biological apatite’s have minor elements in its structure, 
such as magnesium or sodium, which play an important role in its biological 
properties.  
Therefore, scientists have focused on modifying the structure and composition of 
hydroxyapatite in order to achieve a greater similarity to the bone’s composition. 
These modifications were performed by ionic substitutions of calcium ions 
different by cations such as Strontium, Magnesium and Zinc to improve the 
crystallographic, chemical, biological, morphological, thermal, mechanical, and 






The main purpose of this project is to synthetize and characterize multi-
substituted hydroxyapatite powders. In this study, the hydroxyapatite will be 
synthetized and substituted with two methods: ball milling and sol-gel process. 
The hydroxyapatite will be substituted with magnesium and strontium to improve 
osteogenesis of bone tissues and zinc to add antibacterial properties. The 
synergy of the ion substitutions obtained will be studied by the bioactivity against 
Primary Human Osteoblasts. 
To sum up, the main objectives of this project will be displayed below: 
- Synthetize hydroxyapatite with Magnesium, Strontium and Zinc 
substitution by two methods: sol-gel and ball milling.  
- Compare Sol-gel and Ball-Milling as methods to obtain substituted 
hydroxyapatite by powder characterization: 
o Study powder morphology and composition homogeneity  
o Study crystal structure and particle size 
- Determine the cytotoxicity of the powders against Primary Human 
Osteoblasts following ISO 10993. 
- Study feasibility of the obtained powders to be used in plasma spray 
processes. 
- Give an overview of the economic viability of the project 
- Identify and analyse the main limitations as well as expose some possible 
improvements. 
Moreover, apart from check which methods enhances the most 
osseointegration, this project it has also been useful to be able to experience 
the economic feasibility of each method, as well as determine the time needed 
to synthetize hydroxyapatite in each process and also check its difficulty 
degree.  
In addition, it has also been a purpose to help and try to provide knowledge 
to the study group, as well as expand my knowledge of material engineering 
by working in a laboratory and using specialized equipment intended for 








3. SCOPE AND SPAN 
The scope of this project has been limited by time. The project includes the study 
and synthesis of hydroxyapatite by two different methods: sol gel and ball-milling. 
The structure of the obtained powders has been characterized. Moreover, 
cytotoxicity of powders against primary human osteoblast cells has been tested 
It has been assessed the modification of the structure of hydroxyapatite 
experiments by incorporating these ions by studying the crystallographic phase 
composition. The last part of this project is the attempt to coat Ti-6Al-7Nb 
substrates by plasma spraying using the powders produced. 
The main limitations of this project are the high number of samples to be 
synthesized and the time spent on it. Approximately 2 days are needed per each 
sample. Time was a limiting factor, because was not possible to achieve the 
enough powder fluidity to coat the titanium samples. An optimization of the 
agglomeration/particle size reduction is needed for both samples. 
3.1. FORMATION OF PLACE PROJECT 
The study has taken place at the Materials Science and Physical Chemistry 
Department at Physics and Chemistry Faculty of the University of Barcelona, 
specifically at the CPT, that stands for Thermal Projection Centre. 
In order to study the cytotoxicity powders against cells it has been needed the 
















4.1. State of the situation 
Titanium and derived alloys have been intensively used as implant materials due 
to their very good mechanical and corrosion resistance and biocompatibility.  
Titanium alloys are the most commercialized to fabricate orthopaedic implants. 
Ti-6Al-4V alloy was the first alloy registered as metallic implant due to its fatigue 
strength and biocompatibility [10]. However, Challa et al.[3] in 2013 have 
demonstrated that the presence of vanadium in the alloy cause toxicity due to the 
amount of ion release. Therefore, free-vanadium alloys such as Ti-6Al-7Nb 
gained attention [11]. However, other materials such hydroxyapatite started to be 
used in order to enhance osseointegration and improving the biocompatibility of 
the metallic implants. 
 Structure and properties of     
hydroxyapatite 
Bone is a specialized mineralized connective tissue which its 33% of weight 
corresponds to the organic matrix. The organic matrix is mainly composed by 
hydroxyapatite, which constitutes the 67% of bone. For this reason, Hap has been 
and is being investigated as a possible material for coatings and composites. 
Calcium phosphates are a family of ceramic materials containing calcium ions 
(Ca2+) and orthophosphates (PO43-). However, among these ceramic materials, 
synthetic hydroxyapatite is the material which its use has extended due to is the 
major component of bones [12].  
Synthetic Hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) is a bioceramic formed by 
calcium, phosphorus and hydrogen atoms. Hap is a type of apatite, which are a 
group of phosphate minerals.  The structure of Hap is hexagonal unit cell, with a 
lattice parameters of a =b= 9.432 Å and c = 6.881 Å [13]. Its formed mainly by 
calcium and phosphate ions and has a stoichiometric Ca/P ratio of 1.67. In Figure 
1, a scheme of the structure of Hap is displayed: 
 




Hydroxyapatite is the most stable calcium phosphate under physiological 
conditions, such as temperature or composition of body fluids. Moreover, it is a 
biocompatible ceramic material, therefore, it does not produce toxic and 
immunological response when is exposed to body fluids and interacts with the 
surrounding medium. Lastly, as hydroxyapatite has a great similarity the mineral 
phase of the bone, it can enhance the adhesion and proliferation of surrounding 
cells.  
In Table 1, the main properties of hydroxyapatite are displayed: 
Table 1: Main properties of hydroxyapatite. 
Hap it is a fragile and a brittle material. However, its properties are highly-
dependent on its grain size, density, which depend on in which conditions the 
hydroxyapatite has been synthetized.  
Even though hydroxyapatite has greater similarities with bone composition, 
biological apatites have a different composition, crystal size and morphology from 
synthetic hydroxyapatite [15]. In Table 2, the differences and similarities between 
hydroxyapatite and human tooth are exposed: 
Table 2: composition of human tooth enamel and hydroxyapatite. 
 Synthesis methods 
The hydroxyapatite has been widely studied since 1926. Since then, a huge 
amount of applications has emerged. Moreover, several methods for the 
synthesis of hydroxyapatite has been discovered. They can be classified in to 
three main groups, as it is displayed in Figure 2: 
Properties Value 
Density(g/cm-³) 3.15 
Young module (GPa) 90 
Hardness (Mohs) 5 
Fusion temperature (ºC) 1660 
Thermal Expansion coefficient (K-¹) 11 · 10⁴ 
Composition of hydroxyapatite and human tooth emanel 
Constituent Human tooth enamel(wt%) Hydroxyapatite(wt%) 
Ca 36.4 39.9 
P 17.8 18.5 





Figure 2: Scheme of the main synthesis methods of hydroxyapatite. 
- Dry methods: there are two different methods, which are solid-state and 
mechanochemical methods. In the dry method, the precursor chemicals, 
which are calcium and phosphate, are in a dry form [16]. Both precursors 
are mixed to synthetize the Hap. 
o Solid state method: consist on the decomposition reaction of mixed 
solid reactants, in this case, calcium and phosphate precursors, by 
heating with the aim of producing new solids and gases [17]. The 
mechanism of this method is by solid diffusion.  
o Mechanochemical method: technique which employs 
compression, shear, or friction via grinding and milling to induce a 
chemical transformation [18]. The most popular technique is ball 
milling, in which the solids can be grinded at different frequencies 
and at different times [19].  
 
- Wet methods: these methods consists on the use of aqueous solutions 
during the synthesis of Hap [16]. 
o Chemical precipitation: undergoes different processes. Calcium 
and phosphates are mixed, according to a certain molar ratio [20]. 
During this mixture, pH and temperature are adjusted [21]. A heat 
treatment is needed to stabilize the hydroxyapatite crystalline 
structure. 
o Hydrothermal: methods which implies the reaction in aqueous 
media of calcium and phosphate precursors under high 
temperature and pressure conditions [22]. 
o Hydrolysis: the least used method for synthetizing hydroxyapatite. 
It consists on a water ionization process which induces the diffusion 
of hydroxide ions. The hydrolysis of calcium phosphates may 
induce the formation of Hap (non-stoichiometric). 
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o Sol-gel method: this method involves the formation of a colloidal 
sol, which consist on a suspension of colloidal particles in a liquid, 
which will subsequently turn into a gel [23]. Sol gel is the chemical 
process that consist on the transition from a liquid to a solid.  It 
requires a drying process and a thermal treatment in order to 
produce hydroxyapatite. 
 
- High-temperature methods:  those methods consist on producing Hap 
using high-temperatures in order to decompose the precursor’s materials 
[16]. Combustion and pyrolysis are examples of high temperature 
methods. Those techniques are rarely used.  
In this project were selected ball milling and sol-gel methods to produce the 
substituted hydroxyapatite powders. 
 Main applications of hydroxyapatite 
Hydroxyapatite has several applications on the biomedical field: 
- Bone filling 
- Coating implant surface 
- Drug-delivery system 
Firstly, treatment of large bone defects caused by tumours, traumas or infections 
normally requires bone grafting surgery [24]. Inorganic composite material can 
mimic real bones; therefore, Hap can have a potential use on bone filling, due 
to it provides scaffold for bone in growth. 
Moreover, another recent application is using the hydroxyapatite nanoparticles 
as a drug-delivery system [25]. The porous and nanocrystalline Hap has a great 
interest as a drug delivery system due to its nontoxicity and biocompatibility. It’s 
mainly used as skeleton drug delivery system in bone disorders, such as 
osteoporosis. 
Finally, coating with hydroxyapatite the implant surfaced has been founded as 
a potential and interesting application of the hydroxyapatite, due to it will enhance 
osseointegration, chemical stability and biocompatibility to the orthopaedic 
implant. Hap coatings can be achieved through different techniques [26].  
 Substituted hydroxyapatite 
In orthopaedics and dentistry, the use of calcium-phosphate based bioceramics, 
such Hap for coating implants, has shown potential application due to is high 
biocompatibility and its similar composition to natural bone. 
Biological apatites are calcium-deficient and less stoichiometric, with a Ca/P ratio 
of 1.5. Biological apatites belong to a family of minerals called apatites, which 
respond to the composition of Ca10-x(HPO4)x(PO4)6-x(OH)2-x. Its chemical 
structure facilitates the exchange and substitution of other elements. Biological 
apatites have have minor elements, such as carbonate, magnesium, sodium 
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which play an important role in the biological properties of the apatite and modify 
its properties, such as increasing its solubility.  
The bioactive behaviour of stoichiometric Hap can be improved by ion 
substitution. This substitution can be achieved either by cations (Sr2+, Pb2+, Mg2), 
which will occupy the position of Ca2+, and by anions, such as CO32− [27].  
Depending on the ionic substitutions, different properties will be enhanced. In this 
section some examples of ionic substitution will be explained. 
- In the case of Silicon substitution, it has been demonstrated that the 
bone and cartilage growth may be increased due to the presence of Si will 
lead to an increase in bone mineral density [28].  
- Secondly, Silver substituted hydroxyapatite has great benefits. The 
incorporation of silver ions in hydroxyapatite has an effective antimicrobial 
agent. Consequently, it may prevent orthopaedic and dental implant 
infections [29]. 
- Moreover, using magnesium might enhance bioactivity and 
biocompatibility of the Hap due to this element is present on teeth and 
bones. A suitable presence of Mg might lead to an increase of bone mass 
and will enhance the proliferation of osteoblasts [30]. 
- Strontium substitution have similar effects than magnesium substitution, 
due to the presence of Sr induce osteoclast apoptosis, and therefore, 
maintain bone formation and osteoblast proliferation. Zhu et al., 2018 
proved that Sr substituted Hap show enhanced biocompatibility and 
bioactivity [30]. 
- Furthermore, zinc is an abundant element on bone tissues. The presence 
of zinc might promote bone formation, cell differentiation and proliferation 
of osteoblast. It might also reduce the inflammatory response. In addition, 
HA-Zn coating showed moderate antibacterial properties against Gram- 
and Gram+ bacteria [31], [32].  
 
In the following Table, the main properties provided by each ion substitution are 
displayed: 
Table 3: Main properties given by each ion. 
To conclude, it has been demonstrated that multi-substituted Hap show similarity 
with the inorganic phase of bones and it may induce a synergic effect might have 
advantageous effects on bone regeneration [33].   
 Function and properties of each substitution 
 Silicon  Silver Magnesium Strontium Zinc 
Antibacterial properties      
Osteoblast proliferation      
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 Coating methods 
Since the early 1980s, the hydroxyapatite has been often used as a coating 
material of the metal (Ti) substrate due to it provides bioactivity and 
osseointegration to the implant [34]. Different coating methods have been 
emerged.  
The production methods of Hap coatings can be divided in two groups [34]: wet 
chemical deposition techniques and physical deposition techniques. Each 
coating method will reproduce different layer characteristics. 
Physical deposition techniques 
- Thermal Spraying techniques: the coating material is heated and sprayed 
on the substrate. Includes high temperature and velocity. Depending on 
the heat method, there are different thermal spray techniques, for example 
plasma spraying [35]. 
 
 
Figure 3: Schematic view of a plasma spraying gun and the powder deposition method [36]. 
- Electrophoretic deposition: consist on a coating method that consists in 
depositing charged colloidal Hap particles onto a substrate with an 
opposite charge. Particles are moved and driven by an electric field [37]. 
 
Figure 4:Scheme of the electrophoretic deposition process [38]. 
- Physical vapour deposition: they are also called sputtering techniques. 
Those methods use a high energetic beam of ions or electrons projected 
onto a calcium phosphate target. The calcium and phosphate ions will be 




Wet chemical deposition techniques: Chemical deposition techniques coat the 
substrate with solutions or suspensions. Some techniques are explained below: 
- Chemical vapour deposition technique: consists in the exposure of the 
substrate to volatile precursors which will react or decompose on the 
substrate surface [39]. 
- Biomimetic deposition techniques: this method consist in mimicking 
natural manufacturing methods to generate biological apatites.  
- Sol-gel method: there are two different deposition techniques.  
o Spin coating, which the material (sol) is dissolved and dispersed 
into a solvent, and then the sol in dropped into the substrate 
surface. A spinning is performed in order to produce the layer.  The 
step processes can be seen in Figure 5: 
 
Figure 5: Spin coating methodology process [40]. 
o Dip coating consists in the immersion of the substrate into a solution 
containing the coating precursors (the hydroxyapatite sol-gel). The 
substrate is soaked at a constant speed and the coating is 
deposited during the substrate withdrawal. The different steps 
during the coating can be observed in Figure 6:  
 
Figure 6: Dip coating methodology process [40]. 
In this project has been chosen plasma spraying as a deposition method because 
is the most commonly used commercial method to produce hydroxyapatite 
coatings on orthopaedical metallic implants. 
4.2. State of art 
As the number of surgeries as joint replacements has increased substantially, 
researchers have been focusing into enhancing implant osseointegration and 
decrease the recovery time to improve the quality of life of patients.  
In order to increase biocompatibility it is necessary to study the synergy between 
synthesis methods and coating procedures to improve not only the mechanical 
properties, but also the reactivity of the bioactive coatings to increase cell-implant 
interaction that results into a better osseointegration [41].   
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5. MARKET ANALYSIS 
 
Behind every successful product or project, a market analysis is essential in order 
to analyse the current situation and its future perspectives. The economy, the 
going market trends and the traits of costumer’s expenditure will be analysed by 
searching and studying the incidence and frequency of use of hydroxyapatite-
coated implants.  
It is a fact that the number of articles, patents and designs discussing about the 
use of calcium-based compounds is increasing due to the high interest of those 
materials. This rising interest from scientist in these materials, such as 
hydroxyapatite, has led to an increase in interest of powerful companies. 
Because of the market analysis, it will be possible to evaluate the economic 
situation and identify the principal companies which are investigating on the 
modification of surface implants with hydroxyapatite.   
5.1. Current situation 
Hydroxyapatite has several applications in the biomedical field. In the beginning, 
Hap was used for bone grafting. As years passed, hydroxyapatite started to be 
used as a scaffold in order to enhance osseointegration.   
The hydroxyapatite market can be segmented depending on its application. Hap 
can be used in orthopaedic field, in dental care and in plastic surgery. Hap is used 
as a material for coating implants, for bone filling and for bone grafts. 
In 2019 the hydroxyapatite market was led by the orthopaedic group. The global 
population is aging rapidly due to the increasing life expectancy and the reduced 
birth rate on countries. Such increase in the number of senior people has led to 
a rise of orthopaedic surgeries. 
Normally, hydroxyapatite is used as a material to coat implant surfaces needed 
in orthopaedic surgeries. This market segment is expected to grow. The most 
common orthopaedic surgeries are knee and hip replacements. The number of 
hip replacements performed in the United States have increased substantially. 
Over more than ten years of study, the number of surgeries doubled.   
The principal companies who are working on implants and researching on the 
benefits of use of hydroxyapatite are FLUIDINOVA (Portugal), SofSera 
Corporation (Japan), Berkeley Advanced Biomaterials (US), Taihei Chemical 





5.2. Evolution and future perspectives 
As there is an increase in elderly people and in prevalence of chronic diseases, 
the implant global market as well as the hydroxyapatite market is projected to 
grow in the next years. 
During last years, the demand of implants, as well as the use of bioactive 
ceramics, such as hydroxyapatite in implant surgeries has increased rapidly.  
The medical implants market was estimated at USD 89,230 million in 2020, and 
expected to increase with a CAGR of 6.5 during the next 6 years[42].  
The use of Hap coatings on orthopaedic and dental implants has been known as 
early as the 1980s. However, recently, nano-structured hydroxyapatite is gaining 
attention due to is expected to have better bioactivity. Studies have suggested 
that thinner Hap layers, in the nanometer range, reported increased cellular 
response than thicker Hap layers [43].  Moreover, it’s been studying important 
application of nano-structured Hap, such as drug delivery. Using Hap as 
therapeutic drug/antigens/protein carrier provides slow rate of release and 
protection from degradation [44]. Furthermore, there are more trends of use of 
hydroxyapatite which include applications such as its use for purification of 
antibodies on an industrial scale, as an artificial blood vessel or trachea, as well 






6. CONCEPTION ENGINEERING  
6.1.  Proposed solution 
The aim of this study is to compare two different methods to achieve the 
substitution of hydroxyapatite powders: ball milling method and sol-gel 
method. The substitution will be done using magnesium, strontium and zinc as 
target cations for the substitution. 
Finally, the powders obtained will be used to coat Ti-6Al-7Nb samples using 
plasma spray as a coating technique.  
6.2. Selection of substitution methods. 
There a wide variety of methods of hydroxyapatite synthesis, as well as there are 
several coating methods. In this section, it will be argued the reasons why the 
sol-gel and ball-milling methods have been chosen to synthetize the substituted 
hydroxyapatite powders.  
 The sol-gel method has been because it is a process in which 
hydroxyapatite can be synthetized from a cheap calcium and phosphate 
sources and it does not require expensive equipment or advanced 
technology. Also, the substitution can be achieved before the 
hydroxyapatite synthesis by the incorporation of the ions into the sol 
solution using non-expensive salts as precursors of the ions to substitute. 
In addition, with this method, uniform and crystalline hydroxyapatite can 
be synthesized. 
 Ball milling has been chosen as a technique of substitution of 
hydroxyapatite because it is method that can easily implemented at an 
industrial level. The ionic substitution can be achieved by using 
commercial Hap powders to be mixed with the oxide of the atoms selected 
for the substitution. 
 
 Alternative synthetic and substitution 
methods. 
There are other techniques, for example, chemical precipitation method, which 
have great advantages such as is a low cost and easy technique, however, the 
hydroxyapatite obtained normally has a poor uniformity and particles may be 
agglomerated. 
Moreover, high temperature synthetizing techniques has been rejected due to 
they provide a poor control over the processing parameters[16]. Therefore, 





6.3. Selection of coating methods 
The second objective of this Bachelor thesis was to coat the surface of Titanium 
samples with the Hap previously synthetized. 
 Plasma spray coating method has been selected because plasma 
spray is the most used coating technique to produce commercial 
orthopedical implants as knee or hip implants. This method has great 
advantages such as high deposition rate, high adhesion strength and it is 
possible to form a layer of larger thickness than other techniques.  
Other coating techniques that could be used are: 
- Sol gel-deposition method that can be achieved by two strategies, dip and 
spin coating. Both are simple and cost effective. A great advantage with 
respect to plasma spray is that those methods do not use high 
temperatures, and therefore, no amorphous coating will appear. The 
biggest disadvantage is the low adhesion strength of the coating obtained 
that is not suitable for application where frictional forces are applied to the 
substrate. 
- Electrophoretic deposition: This technique showed great benefits such as 
the layer thickness can be adjusted through the applied voltage. In 
addition, it allows to form homogenous and uniform layers. However, the 
main drawback is the shrinkage and cracking that often appear during the 
coating process. 
To sum up, plasma spray has used for coating titanium substrates due to its 
apparently high efficacy and deposition rate, as well as because the equipment 
was available in the laboratory. 
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7. DETAILED ENGINEERING  
 
7.1. Sample code 
The code used for each sample follows a pattern: 
𝑯𝑨_𝑴𝑬𝑻𝑯𝑶𝑫𝑶𝑳𝑶𝑮𝒀_𝑬𝑳𝑬𝑴𝑬𝑵𝑻_𝑵𝑼𝑴𝑩𝑬𝑹_𝑪𝑶𝑵𝑪𝑬𝑵𝑻𝑹𝑨𝑻𝑰𝑶𝑵%_𝑻º_𝑯𝑶𝑼𝑹𝑺 
- HA corresponds to hydroxyapatite code.  
- Methodology can be either sol gel which will be denoted as “SG” or ball 
milling, which will be written as “BM”. 
- Element that will be used in order to substitute the hydroxyapatite. 
- Number will correspond to the number of specific samples performed to 
differentiate the sample replicates. 
- Concentration will correspond on the molar percentage of the ion 
substitution.  
- Temperature and hours will determine which thermal treatment has been 
done. 
An example of sample code will be the following: 
“HA_SG_Mg_PA001_2,5%_600ºC_1h” 
The sample was obtained by sol-gel methodology. The hydroxyapatite is 
substituted with Magnesium element with a molar concentration of 2.5%, 600ºC 
and 1 hours is the temperature and time of the thermal treatment that the sample 
has been exposed to.  
7.2. Experimental procedure 
In this section the synthesis process of the Hydroxyapatite powders will be 
explained. In this Bachelor thesis, two different synthesis methods of powders 
have been considered: Sol-gel method and Ball-milling process 
 Sol-gel synthesis of hydroxyapatite 
The methodology of this procedure was adapted from [45]. The calcium precursor 
was calcium nitrate tetrahydrate (Ca(NO3)2· 4H₂O, Sigma-Aldrich, CAS : 13477-
34-4) and the phosphorus precursor was triethyl phosphite (C₂H₅O)₃P, Sigma-
Aldrich, CAS: 122-52-1).  
Briefly, 21.92g (0.0928 mol) of calcium nitrate tetrahydrate was dissolved in 50mL 
of absolute ethanol (CH₃CH₂OH, Sigma-Aldrich, CAS: 64-17-5) and added 
dropwise to 10mL of triethyl phosphite (0.058 mol) at a dropping rate of 1mL/min. 
The reaction was carried out maintaining a molar ratio (Ca/P)=1.6. The prepared 
solution was then placed in a water bath set at 70±10ºC and aging overnight 
closely capped. The gelation was done drying the solvent in the same water bath 
until a viscous precursor was obtained. The precursor was then dried in an oven 
at 90ºC overnight a powder sample was obtained. Finally, the powder was 




For the substituted-Hap preparation the methodology explained previously was 
adapted to maintain the molar ratio (Ca+M/P)=1.6, where M is referring to metallic 
ions (Zn2+, Mg2+ and Sr2+) to substitute calcium atoms on the hydroxyapatite 
structure.  
The metallic salts used are Zinc Chloride (ZnCl₂, Sigma-Aldrich, CAS: 7646-85-
7), Strontium Chloride (SrCl₂ anhydrous ≥99.9%, CAS: 10476-85-4) and 
Magnesium Chloride (MgCl₂ anhydrous ≥98%, Sigma-Aldrich, CAS: 7791-18-6). 
The salts were dissolved in absolute ethanol and added dropwise simultaneously 
than the calcium nitrate solution to the triethyl phosphite. The prepared solution 
as placed in a water bath set at 70±10ºC and aging overnight closely capped. 
The gelation was done drying the solvent in the same water bath until a viscous 
precursor was obtained.  
All the samples were dried in an oven at 90ºC overnight followed by a thermal 
treatment at 600ºC for 1 hour in a furnace with oxidant atmosphere in order to 
stabilize the crystal structure.  
Once the powders were obtained, they were washed with Mili-Q water and a 
vacuum pump in order to eliminate ions that could interfere with a correct 
characterization of the samples. Finally, samples were dried in an oven at 90ºC 





Figure 7: Sol-gel methodology scheme. 
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In the Table 4, all the different synthetized samples are displayed, indicating the 
quantity in grams of each component.  
Table 4: Composition of each component in samples obtained by sol-gel. 
 Ball Milling synthesis of 
hydroxyapatite 
The methodology of this procedure was adapted from the protocol of Dra. Bose 
[12]. It has been chosen this methodology due to the availability of the equipment.  
The powders were prepared by mixing commercial Hap (Ca₁₀(PO₄)₆(OH)₂, 
Sigma-Aldrich, CAS: 1306-06-5) with the oxide elements desired for the 
substitutions, Strontium Oxide (SrO, Sigma-Aldrich , CAS: 1314-11-0), Zinc 
Oxide (ZnO, Sigma-Aldrich , CAS: 1314-13-2) and Magnesium oxide (MgO, 
Sigma-Aldrich , CAS: 1309-48-4). The metallic oxides were mixed with 
commercial Hap in different concentrations: 1%, 2.5% and 5% molar, using a 1:1 
milling media to powder ratio at 240 rpm during 6h. The mixture was performed 
in a PM 400 MA-type ball-milling machine.  
In the following table all the different obtained samples are displayed, indicating 
the quantity of each component: 
Table 5: Quantity of component in each sample produced by ball-milling. 













HA_SG_PA007 21.92 10    
HA_SG_Mg_PA002_2,5% 21.36 10 0.356   
HA_SG_Sr_PA002_2,5% 21.36 10  0.533  
HA_SG_Zn_PA001_2,5% 21.36 10   0.48 
HA_SG_Mg_Zn_PA001_2,5% 21.36 10 0.149  0.244 
HA_SG_Sr_Zn_PA001_2,5% 21.36 10  0.266 0.244 
HA_SG_Sr_Mg_Zn_PA001_2,5% 21.36 10 0.0995 0.177 0.162 







MgO2 (g) SrO₂ (g) ZnO2 (g) 
HA_BM_MgO_2,5% 25.05 25 0.05   
HA_BM_SrO_2,5% 25.128 25  0.128  
HA_BM_ZnO_2,5% 25.1 25   0.1012 
HA_SG_Mg_Zn_2,5% 25.076 25 0.025  0.051 
HA_SG_Sr_Zn_2,5% 25.115 25  0.065 0.051 
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7.3. Characterization methodology 
The samples obtained by sol-gel and ball-milling methodology have been 
characterized its chemical composition with IR, the homogeneity of the elemental 
composition with SEM, its crystalline structure with DRX and its mean particle 
size with laser scattering. Moreover, cytotoxicity assays have been performed. 
 X-Ray Diffraction 
The measured samples were powders, which have been placed in cylindrical 
standard sample holders of 16 millimetres of diameter and 2.5 millimetres of 
height. An X-Ray Diffraction test with PANanalytical X’Pert PRO MPD alpha1 
powder diffractometer in Bragg-Brentano θ/2θ geometry of 240 mm of radius and 
Cu Kα1 radiation (λ = 1.5406 Ȧ) was performed. The /2 scan was from 4 to 120º 
2 with step size of 0.026º and the measuring time was 150 seconds. In each 
measurement, three repeated consecutive scans were performed. 
To quantify the amount of beta tetra calcium phosphate founded in each sample 
the methodology described by Landi, et al.[46] was used. The Relative Intensity 
Ratio (RIR) can be estimated using the intensity peaks of (2 1 1) and (0 2 10) of 
HAP and B-TCP, respectively. In this project the formula used is Equation 1. 
Equation 1. RIR 
𝑅𝐼𝑅 =  
𝐼B − TCP
𝐼HAP+ 𝐼B − TCP
∗ 100 
Where IB−TCP  corresponds to the intensity peak, measured in number of counts, 
of the peak situated in the plane (0 2 10) of the beta-tricalcium phosphate. The 
IHAP corresponds to the hydroxyapatite intensity peak situated in the plane (2 1 1).  
 
Furthermore, Landi describe a method to characterize the degree of crystallinity 
of the samples using the Equation 2: 
 
Equation 2. Degree of crystallinity 





Where V112/300 corresponds to the intensity hollow between (1 1 2) and (3 0 0) 
peaks. And I3 0 0 is the number of counts of the peak (3 0 0) intensity plane. This 
method will be used to verify that if by adding ions, the crystallinity of the samples 
is reduced. 
 
In order to measure both parameters, a baseline and a smoothing of the spectrum 
was done. 
 
HA_SG_Sr_Mg_Zn_2,5% 25.187 25 0.033 0.087 0.067 
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  Infrared spectroscopy (IR) 
 
A FTIR spectrometer (Perkin Elmer- Spectrum two) has been used in order to 
chemically characterize the samples.  
 
 SEM characterization 
 
A secondary electron microscope has been used in order to measure the 
homogeneity and morphology of the composition. The SEM used  
An energy dispersive X-ray spectroscopy has been used in order to detect the 
chemical composition of the analysed sample, using an elemental mapping of the 
samples to verify the homogeneity of the sample. 
It has been worded with a voltage of 20000KV and with a working distance of 
20mm. 
 
 Laser scattering characterization 
 
A laser scattering characterization has been performed in order to measure the 
particle size distribution of the sample. The particle-size distribution of the HA-
powders were studied using laser diffraction LS 13 320 XR (Beckman Coulter®) 
in a dry powder system with a Fraunhofer as an optical model. 
 
 Cytotoxicity protocol 
Primary Human Osteoblasts (HOB) isolated from femoral trabecular bone 
following the protocol described by Nacher[10] from a knee joint after an 
arthroplasty were used as a cell line. The Parc de Salut Mar Ethics Committee 
approved the study and the use of primary osteoblastic cells. An initial cell density 
of 1x104 cell/well were incubated during 24h at 37ºC in 5% CO2 humidified 
chamber in 96-well culture plates. 
The cell viability with the powder was done according ISO 10993-5:2009 
performing the test with a confluent cell monolayer. The extraction vehicle 
selected was a culture medium with serum (DMEM, Dulbecco) as its supports 
cellular growth and can extract both polar and non-polar substances.  
Briefly, 0.1 g of Hap-powder was mixed with 1mL DMEM and incubated for 48±2 
h at 37±1ºC in a 5% CO2 humidified chamber. At the end of the incubation period, 
the Hap-powder was removed by centrifugation and the extracts were used at 
various concentrations (100%, 50% and 10%). 
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 A cytotoxic effect was considered positive if the reduction of cell viability was 
higher than 30% and cell proliferation was quantified by CellTiter 96®️ 
AQueous One Solution Cell Proliferation Assay (MTS) (Promega). After the 
control of systematic cell seeding and growth errors the culture medium was 
removed and discarded; it is mandatory to eliminate all the culture medium since 
can contain reductive chemicals that can react and reduce the MTT (3-(4,5-
dimethylthiazol-2-yl).2,5-diphenyltetrazoliumbromid) reagent.  
The proliferation was quantified by the reduction of MTT that can be determined 
by spectroscopic measurements at 570 nm wavelength. After the elimination of 
the culture medium, 50 µL of MTT solution (1mg/mL of MTT in DMEM) was added 
to each well and the solution was allowed to incubate during 2h before remove it. 
Lastly, a 100 µL of isopropanol was added to each well and the absorbance of 
the solution was measured in a microplate reader equipped with a 570 nm filter. 
One positive control and one negative control were introduced in the assay. The 
positive control corresponds to commercial hydroxyapatite to be able to compare 
with ball milling results and hydroxyapatite produced by sol-gel to compare with 
the different samples made by this method. For each type of sample, the assay 
was repeated three times, therefore, for each sample three different absorptions 
were obtained. An average of these three was made and the standard deviation 
of each of them was calculated. The cell viability of each sample was obtained 
using the following equation: 






Where “As” is the absorbance obtained of the measured sample and “Ac” 
corresponds to the absorbance of the control. 
 Plasma-spray coating 
 
Powders obtained by ball milling and sol-gel methodology were used. The Hap 
coatings were sprayed onto a Ti-6Al-7Nb surface with an A3000 F4 Plasma 




Figure 8: Plasma Spray machine 
 
The Hap coating conditions are described in Table 6: 
General conditions for deposition of Hap coatings with plasma spray  
Power (KW) 68(40-60) 
Argon flow (L/min) 50 
Hydrogen flow (L/min) 1 
Current (A) 500 
Voltage(V) 51.5 
Projection distance(mm) 80 
Number of steps 5 
Table 6: General conditions for deposition of Hap coatings with plasma spray. 
 
Before spraying the hydroxyapatite towards the surface, roughness of sample’s 
surface must be increased in order to enhance the adhesion of coating. A shoot 
peening of titanium alloy surfaces with alumina particles has been conducted.  
7.4. Results 
Although during the work in the laboratory more samples have been synthesized, 
with different concentrations and different ions, only the tri-substituted 





 Selection of thermal treatment 
conditions for sol-gel samples. 
 
Before starting the characterization and synthesis of the substituted 
hydroxyapatite, it is essential to choose the optimal heat treatment that the 
powders will receive in order to avoid the destabilization of Hap crystalline 
structure. 
Sol-gel sample were subjected to different heat treatments, at 600ºC, 700ºC, 
800ºC, 900ºC and 1000ºC. In the Figure 9, the DRX spectrum of each sample 
are displayed. The peaks corresponding to each phase has also been specified. 
The peaks appearing in blue colour corresponds to Hap and the peaks in red are 
the specific of beta tetracalcium phosphate (TCP). Two diffraction papers have 
been used in order to detect each phase. For B-TCP, the reference code of the 
diffraction paper is 00-009-0169. (Peaks related to this phase will be highlighted 
in red). For Hap, the reference code of the diffraction paper corresponds to 01-
084-1998, which will be highlighted in blue. 
As it can be observed, the intensity of the peak corresponding to Hap, which 
corresponds to the plane (1 2 1), in the red square, decreases as the temperature 
increases.   
  
 
Figure 9: DRX spectrum of samples treated at different temperatures. 
 
 
In the following table, the RIR of B-TCP has been measured for each 
temperature. As it can be observed, the B-TCP RIR ratio increases with 
temperature, therefore, as temperature increase, less hydroxyapatite phase 




RIR of samples depending on thermal treatment conditions 
Sample code Temperature (Cº) RIR (%) 
HA_SG_PA007_600_3h 600  58.6 
HA_SG_PA007_700_3h 700 72.2 
HA_SG_PA007_800_3h 800 86.3 
HA_SG_PA007_900_3h 900 91.3 
HA_SG_PA007_1000_3h 1000 91.4 
Table 7: RIR parameter is measured for samples with different thermal conditions. 
 
Furthermore, once the 600ºC temperature was selected as the optimal 
temperature for thermal treatment, the time needed was also studied. A DRX was 
conducted for two samples treated at 600ºC but at different time durations (1 hour 
and 3 hours). 
 
In Figure 10, DRX spectrums of hydroxyapatite obtained by sol-gel methodology 
thermally treated at 600ºC and 1 and 3 hours are displayed. The peak which 
corresponds to Hap phase (1 2 1), which is pointed in Figure 10, increased its 
intensity when duration of the heat treatment is reduced. 
 
 
Figure 10: DRX spectrum of samples treated with different time durations. 
 
In the Table 8, the RIR of B-TCP are presented. Samples treated during 3 hours 
had a B-TCP ratio bigger than those treated during 1 hour. Therefore, as time 
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RIR of hydroxyapatite samples 
Code sample RIR (%) 
HA_SG_PA007_600ºC_3h 58.6 
HA_SG_PA007_600ºC_1h 8.9 
Table 8: RIR of samples treated at different time durations. 
Therefore, the heat treatment selected will be with the following conditions: 1 
hour and 600 degrees. These treatment conditions are the optimal due to 
samples showed major hydroxyapatite phase. 
 
 DRX of substituted hydroxyapatite 
 
A characterization by DRX has been performed on the samples of substituted 
hydroxyapatite with the aim of quantifying possible changes in the crystalline 
phase and degree of crystallinity caused by the addition of Magnesium, Zinc and 
Strontium ions.  
In Table 9, RIR and degree of crystallinity parameters have been compared 
between sol-gel Hap and commercial Hap. As it can be observed, commercial 
Hap shows a lower phase ratio of B-TCP and a major crystallinity degree than 
the sample obtained by sol-gel method.  
 
Firstly, as it displayed in Figure 11, a DRX of HA_SG_SrMgZn_2,5%_600ºC_1h 
sample has been compared with the HA_SG_PA007_600ºC_1h.  After the 
cationic substitution, there is an increase of the diffraction peak located in the 
plane (3 0 0), which is highlighted in red in the figure. The increase of this peak 
is caused by the stabilization of beta tricalcium phosphate in substituted 
hydroxyapatite.  
 Comparison between Commercial Hap and Hap obtained with sol-gel 
Sample RIR(%) Xc(%) 
Commercial Hap 0,286 98,4 
HA_SG_PA007_600ºC_1h 8,86 77,56 




Figure 11: DRX spectrum of sol-gel tri-substituted hydroxyapatite. 
In Table 10, the degree crystallinity before and after the ionic substitution is 
displayed. The cationic substitution on sol-gel samples decrease the crystallinity 
of Hap.  
Degree crystallinity before and after ionic substitution of sol-gel samples 
Code sample Degree of crystallinity Xc (%) 
HA_SG_PA007_600ºC_1h 77.6 
HA_SG_Sr_Mg_Zn_2,5%_600ºC_º_1h 50.5 
Table 10: Comparisoin of degree crystalinity before and after the ionic substitution of sol-gel samples. 
 
Moreover, as it is shown in Figure 12, spectrums of commercial Hap and 
substituted hydroxyapatite made by ball milling method are compared. In 
substituted hydroxyapatite spectrum also appears the peak of the plane (3 0 0), 
(highlighted in red). Moreover, as it can be seen in figure x, the substitution of 
Magnesium, Zinc and Strontium ions has increased the width of the peaks. 
Zinc substitution can increase the line width of peaks and reduce the intensities, 




Figure 12: DRX spectrum of ball-milling tri-substitued hydroxyapatite 
 
As it can be observed in table, the crystallinity degree ball-milling substituted Hap 
has been measured. The cationic substitution caused a decrease in the 
crystallinity degree. 
Degree crystallinity before and after ionic substitution of ball-milling 
Code sample Degree of crystallinity Xc (%) 
Commerical Hap 98.4 
HA_BM_Sr_Mg_Zn_2,5% 64.8 
Table 11: Comparison of degree of crystallinity before and after substitution in ball-milling samples. 
 
 IR spectroscopy of substituted 
hydroxyapatite 
Infrared spectroscopy was used to compare the functional groups of commercial 
hydroxyapatite and the sample obtained by sol-gel and thermally treated at 600ºC 
for 1h. HA_SG_PA007_600ºC_1h. 
In the Figure 13, the IR spectrum of commercial hydroxyapatite and sol-gel 
synthetized hydroxyapatite treated with thermal treatment of 600ºC and 1 hour is 
displayed. The first indication for the formation of Hap is the form of a broad FTIR 
band centred at 1000 and 1100 cm-1,, which is highlighted with a black rectangle. 
Also, the signal from the hydroxyl bending (highlighted in purple) band is 
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normally shown at 3570 cm-1, which supports the presence of Hap [47]. 
Moreover, the bands formed at 1092 cmˉ¹ -1034 cmˉ¹  and at 565-601 cm-1 
correspond different symmetric PO stretching vibrations of the PO₄³ ̄  
(phosphate ions, which are highlighted in red)[ 44]. Therefore, it can be confirmed 
the presence of Hap in our samples.  
It is important to notice that the hydroxyapatite produced by sol-gel method has 
a characteristic band from inorganic carbonate ion, (highlighted in blue), which 
is located around 1465-1415 cm-1 is present in the FT-IR spectra of the Hap-sol 
gel sample but is not founded in the commercial Hap [47]. 
 
 
Figure 13: IR spectrums of commercial Hap and hydroxyapatite sol-gel. 
.  
Furthermore, an IR of tri-substituted hydroxyapatite obtained by sol-gel method 
and ball-milling method has been conducted in order to asses and study the 
effects of ion substitution.  
As it can be seen in Figure 14, the multi-substituted sol-gel hydroxyapatite has a 
peak which corresponds to P-O bond stretching of tri-calcium phosphate 
(highlighted in purple). The formation of this peak is related to the stabilization of 
tri-calcium phase induced by cationic substitution. 
This band which corresponds to inorganic carbonate, which is highlighted in 
blue, which is located around 1465-1415 cm-1 does not appear neither in 





Figure 14: IR spectrum of sol-gel sample 
The IR spectrum of ball-milling tri-substituted hydroxyapatite is displayed in 
Figure 15. The main difference between HA_SG_PA001_Sr_Mg_Zn_2,5% is that 
no carbonate has appeared.  
 




In both spectrums, the cationic substitutions can be identified due to slight 
changes in signals. 
The incorporation of strontium has an effect on the phosphate bands, which are 
shifted from higher to lower wavenumbers[48]. V3 phosphate peaks were slightly 
moved to 1092 cmˉ¹ and 1034 cmˉ¹ to 1076 cm ˉ¹ and 1028 cm ˉ¹ respectively. 
This confirms the incorporation of strontium ions in the sample [48]. 
A magnesium substitution can be confirmed due to the decrease of hydroxyl 
vibration intensity peaks. Mg incorporation caused changes in PO₄³  ̄absorption 
band in the form of broadening and splitting of this group [49].Therefore, extra 
peaks ascribed to vibration modes of phosphate characteristic of Mg-B-TCP were 
detected at 945, 974, 988, 1117, and 1152 cm ˉ¹ [49]. 
Finally, zinc incorporation has also changed the spectrum. Zn-substituted Hap 
have lower OHˉ stretching vibrational mode. The incorporation of zinc caused 
that OH stretching band has slightly shifted from lover to higher wavenumber [50]. 
The effects of cationic substitution have been reflected in infrared spectrums of 
HA_SG_SrMgZn_2,5%_600ºC1h and HA_BM_SrMgZn_2,5%, which are 
displayed in figures 14 and 15. Firstly, the cationic substitution decreases the 
intensity of peaks of OHˉ. As it can be observed in both spectra’s, the peak 
which corresponds to OHˉ has decreased. In Table 12, it can be observed in more 
detail the reduction in the intensity of this peak. 














 SEM results 
A SEM image and colour mapping has been performed of 
HA_SG_Sr_Mg_Zn_PA001_2,5% and HA_BM_SrMgZn_2,5%. In Table 13, the 
colour maps and the main results are displayed. 
Table 13: SEM images of ball-milling and solgel samples after the ionic subtitution. 
 
 Laser scattering results 
In Figure 16, the particle size of HA_SG_Sr_Mg_Zn_2,5% sample is displayed in 
function of the volume distribution. It can be observed that the sample has a very 
large particle size variation and is conformed mainly by particles in microns. The 
mean particle size of the sol-gel sample is approximately 50μm. 
SEM Images 
Sol-gel sample  Ball-milling sample 
 
 
Both methods achieve a homogeneous distribution of the substituted elements. 





Figure 16: Particle size vs volume distribution of HA_SG_Sr_Mg_Zn_2,5%_600ºC_1h 
 
Moreover, the particle size of ball-milling hydroxyapatite before and after the 
substitution is presented in Figure 17. The commercial Hap (presented in blue 
line) show a homogeneous particle size around 4 μm. The ball-milling process 
produces a particle size reduction and the samples after ball-milling present a 
particle mean size of 0.5μm.  
However, the particle size needed to coat titanium alloy substrates with the Hap 
must be between 40 and 60 μm. Therefore, an agglomeration of the milled 
powder was conducted in order to increase the particle size. Powders were mixed 
with polyvinyl alcohol (PVA), which is a water-soluble synthetic polymer. For 5 g 
of powder, 1mL of PVA was used. Furthermore, the mixture was then dried in an 
over at 70ºC overnight. Finally, was heated at 300ºC for 1 hour in order to 
eliminate the polymer. As it can be seen in Figure 17, particle size after 




Figure 17: Particle size vs. volume distribution of HA_BM_SrMgZn_2,5% before and after agglomeration process. 
 
To sum up, there is a huge difference in particle size between hydroxyapatite 
synthetized by sol-gel methodology and the sample obtained by ball-milling. 
Both powder samples need an additional step to achieve a correct particle size 
range to be used in plasma spraying process. 
 Cytotoxicity results 
The cytotoxicity of HA_SG_Sr_Mg_Zn_PA001_2,5%_600ºC_1h has been 
studied and compared to the cytotoxicity of hydroxyapatite produced by sol-gel 
method (HA_SG_PA007_600ºC_1h). In Figure 18, the absorbance of MTS of 
each sample is displayed. The reduction in the metabolic activity of human 
osteoblastic cells is 18%.  
 
Figure 18: MTS Absorbance of hydroxyapatite produced by sol-gel methodology. 
Moreover, the cytotoxicity of ball milling substituted hydroxyapatite has also been 
assessed. As it can be seen in the Figure 19, values of MTS absorbance are 
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nearly the same compared to the commercial Hap. In this case, the reduction of 
absorbance is 10%.   
 
Figure 19: MTS absorbance of hydroxyapatite produced by ball-milling 
Both hydroxyapatite samples (HA_SG_SrMgZn_2,5% and 
HA_BM_SrMgZn_2,5%) do not show cytotoxicity against primary human 
osteoblasts cells. The absorbance of MTS was not reduced by more than 30%, 
therefore, the powders are not consider as cytotoxic. 
 Plasma spray results 
 
The roughness of titanium alloy surfaces was increased. Surface roughness 
before shot peeing was of 260nm. After the surface treatment, the 1,1μm of 
roughness was achieved. 
However, hydroxyapatite could not be sprayed correctly to the surfaces of 
titanium alloys. This problem is due to the fact that the obtained powders did not 
flow properly, and consequently, a uniform layer cannot be obtained.  In Figure 
20, it can observe the difference between a proper Hap coating and the coating 
obtained.  
 




The plasma spray technician commented that the lack of fluidity could be 
caused by the small size of the powder particles. Even an agglomeration 
process has been conducted, powders did not flow properly, and consequently, 






8. EXECUTION SCHEDULE 
 
In every project, the management of times and activities is essential in order to 
get successful results. In this section, and EDT will be displayed, as well as 
defining the numerous activities, its time and degree of complexity and also make 
PERT and GANT diagram. 
8.1. EDT DIAGRAMM 
An EDT diagram has been done in order to have a general idea and structure of 
the project. In the following figure, an EDT diagram can be observed. This 
bachelor thesis, has been divided in to five steps: Start of the project, 
Experimental procedure, Experimental analysis, Results and Project delivery. 
 
  
Below, in the EDT dictionary, each block and each activity will be briefly 
explained. 
Reference 1.1 EDT Title Project idea 
Description The activity consists of choosing the project topic among different possible 
theses. 
Responsible  Alex Carrasco 
Duration  3 days 
 
Reference 1.2 EDT Title Literature research 
Description Read and collect information about the structure, properties, applications 
and synthesis methods of hydroxyapatite 
Figure 21: EDT diagram of the project, which expose the main activities performed. 
37 
 
Responsible  Alex Carrasco 
Duration  16 days 
 
Reference 1.3 EDT Title Market analysis 
Description The market situation of hydroxyapatite has been analysed. The total cost 
of the project has been assessed as well. 
Responsible  Alex Carrasco 
Duration  1 day 
 
Reference 2.1 EDT Title Material acquisition 
Description All the required materials and regents were acquired 
Responsible Javier Fernandez and Raisha García 
Duration 3 days 
 
Reference 2.2 EDT Title Synthesis of Hap 
Description The substituted hydroxyapatite was synthetized by ball-milling and sol-gel 
methods 
Responsible  Alex Carrasco 
Duration 120 days 
 
Reference 2.3 EDT Title Hap-coating 
Description Titanium alloy substrates were coated with the Hap obtained through 
plasma spray. 
Responsible  Victor (CPT technician) 
Duration 4 days 
 
 Reference 3.1 EDT Title Characterization of Hap 
Description The synthesized hydroxyapatite was characterized with different methods 
such as DRX, IR, among others. 
Responsible  Alex Carrasco and Raisha García 
Duration 10 days 
 
Reference 3.2 EDT Title Cytotoxicity assays 
38 
 
Description The cytotoxicity of the synthesized powders against osteoblast human cells 
was studied. 
Responsible  Alex Carrasco  
Duration 6 days 
 
Reference 4.1 EDT Title Results discussion 
Description The results obtained were discussed and interpreted. 
Responsible  Alex Carrasco  
Duration 10 days 
 
Reference 4.2 EDT Title Project writing 
Description All the different processes followed in this Bachelor Thesis has been 
written down. 
Responsible  Alex Carrasco  
Duration 25 days 
 
 Reference 5.1 EDT Title Project delivery 
Description The project has been reviewed and delivered through the Campus Virtual 
at the corresponding deadline. 
Responsible  Alex Carrasco  
Duration 1 day 
 
Reference 5.2 EDT Title Project presentation 
Description A project presentation has been prepared in order to expose the main 
parts of the thesis.  
Responsible  Alex Carrasco  












8.2. Pert diagram 
In this section a PERT diagram will be displayed. Firstly, a dependence matrix 


















1.1 A - 2 5 3 3,2 
1.2 B A 15 21 16 16,7 
1.3 C A 1 4 1 1,5 
2.1 D B,C 2 5 3 3,2 
2.2 E D 140 160 150 150 
2.3 F E 3 6 4 4,2 
3.1 G F 7 20 10 11,2 
3.2 H G 5 7 6 6 
4.1 I H 7 12 10 10 
4.2 J I 22 30 25 25,4 
5.1 K J 1 2 1 1,2 
5.2 L K 7 12 5 6,5 
Table 14: Dependence matrix of the project, indicating the time needed for each activity. 
Moreover, a PERT diagram has been done due to is a powerful tool to analyse 
any project task and estimate the amount of time required to complete each 
activity in the project. With this information, it is possible to estimate the minimum 
time needed to complete the whole project. 
Once the diagram is completed, the critical path estimation will be executed. The 
critical path is defined as “the sequence of scheduled activities that determines 
the duration of the project”. In Figure 22, it can be observed the critical path, which 
is highlighted in red and corresponds to: A-C-D-E-F-G-H-I-J-K-L 
 
Figure 22: PERT diagram of the bachelor thesis 




8.3. Gant chart diagram 
This section will detail the time evolution of the work. A Gantt chart diagram have 
been done due to is a useful way of showing activities or events of any project 
displayed against time.  
 
Figure 23: Gantt chart diagram of the different tasks of the project. 
 
The project started in October 2020, where the project idea was proposed. A few 
days were needed to decide the topic of the project. Since then, 16 days were 
foreseen for searching information and read articles and papers. Then, a market 
analysis was performed in order to know the situation in which the project was 
framed.  
At the beginning of November of 2020, the experimental part of the project began. 
First, all the material necessary to synthesize the hydroxyapatite was acquired. 
Then, the synthesis of the hydroxyapatite began. This process took 150 days. It 
started in mid-November and ended in March. The process was long because 
many samples were synthesized. As the best samples were synthesized, a 
characterization of each sample was performed. The synthesized hydroxyapatite 
was used for coating titanium substrates. Several days were spent attempting to 
coat the surface with the synthesized material. Such characterizations began as 
the best samples were synthesized. In addition, cytotoxic assays began in early 
April. As the results came in, they were interpreted and the project was written 
up. 
Finally, in June, the project was reviewed and delivered, and it took five days to 




9. Technical pre-feasibility 
 
SWOT analysis is a strategic planning technique used to identify the strengths, 
its weaknesses, its main opportunities and its threats. Such analysis has been 
done with the aim of identify the internal and external factors which may interfere 
in the project performance.  
 
Figure 24: SWOT analysis which balances the main strengths, weaknesses, opportunities and threats of the project 
The main strength of this project is that the author is a biomedical engineer, and 
therefore has a transversal knowledge on biology and technology. In addition, the 
most prominent opportunities are the use of simple and inexpensive 
hydroxyapatite manufacturing methods. On the other hand, the greatest 
weakness of this thesis is the lack of experience of the author in a laboratory. 








10. ECONOMIC FESEABILITY  
 
In this section the economic feasibility of the project will be examined and study 
in order to determine the overall project budget. This study, normally consist on 
a cost-benefit analysis of the project, and then determine whether it is possible to 
implement it. However, in this section it is only going to be studied the total cost 
of the activities developed. As the aim of this section is to determine the whole 
expenses of the project, they will be divided in 3: Labour costs (or human costs), 
the material needed and used-equipment costs. 
10.1. Labour costs 
Labour costs refer to the sum of all wages paid to employees. In this section, the 
expenses associated with the salaries of the people involved in the work will be 
assessed. 
Firstly, the number of participants has to be determined. The person which has 
performed the thesis is a biomedical engineer.  In Spain, the average salary of a 
biomedical engineer is 40000€ per year, and therefore, the engineer gains 
approximately € 20 / hour. 171 days were worked in the laboratory, and with an 
average of 4 hours worked per day, 686 hours in total were destined by the 
biomedical engineer in the laboratory.  
Moreover, as the biomedical engineer does not have experience on laboratory 
practice and use of equipment, a laboratory supervisor is needed in order to guide 
and contribute partially in the investigation. A laboratory supervisor earns 
40€/hour. Since the supervisor guides the engineer and advises and carries out 
certain activities of more complexity, it will be counted that the hours worked have 
been less. Approximately a total of 55 hours has been worked by the supervisor. 
 
Role Worked hours  Price per hour Total (€) 
Biomedical engineer 686 20 13720 
Laboratory supervisor 55 40 2200 
Total   15920 € 
Table 15: Labour costs of the project 
 






10.2  Manufacturing cost of hydroxyapatite 
This work focuses on synthesizing hydroxyapatite substituted by two methods. 
Even though it is important to compare both methods in terms of characterization 
and cell viability, it is also important to compare in terms of costs. In Table 16, the 
total cost per sample obtained by sol-gel method will be displayed. The number 
of samples obtained by this method are 7. 
Sol-gel method costs per sample 
Material/Equipment Quantity used Price Total(€) 
Calcium nitrate 21.36 g 126€/kg 2.7 
Triethyl phosphite  10 ml 60.8€/L 0.6 
Absolute ethanol 50 ml 23.8€/L 1.2 
MgCl 0.0995 g 144€/kg 0.014 
SrCl 0.177 g 134€/kg 0.02 
ZnCl 0.162 g 128€/kg 0.02 
Oven 12h 0.13€/h 1.56 
Muffle furnance  1h 0.195/h 0.195 
   6.2 €/sample 
Number of conditions 7 43.2€ 
Table 16: Costs of the sol-gel method process. 
Moreover, as shown in Table 17, the total cost of producing hydroxyapatite by 
ball-milling methodology is displayed. Six samples were synthetized: 
Ball-milling method costs 
Material/Equipment Quantity Price Total(€) 
 Commercial Hap 25 g 800€/kg 20€ 
MgO 0.033 1712€/kg 0.05€ 
SrO 0.087 1670€/kg 0.14€ 
ZnO 0.067 1868€/kg 0.13 
Zirconia 25.2 g 53€/kg 1.4 
Agglomeration process 1 2€/process 2 
Milling Machine 6h 0.4€/h 2.4 
   26.04€/sample 
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Number of conditions 6 156.2 € 
Table 17: Costs of the ball-milling process. 
10.3. Characterization costs 
The characterization process has also been considered in the overall project 
budget.  
The methods of characterization employed are SEM Microscope, Infrared 
Spectroscopy, X-Ray diffraction and laser diffraction in order to measure powder 
size. Finally, a cytotoxicity assay has also been conducted. The number of 
samples which were characterized are four. 
Characterization costs 
Material/Equipment Hours Price/hour (€/hr) Total(€) 
DRX 2h/sample 35 70 
IR 10min/sample 30 5 
SEM 20min/sample 15 5 
Laser scattering 1h/sample 25 25 
Cytotoxicity 1h 500 500 
 605 
Number of conditions 4 2420€ 
Table 18: Characterization costs of the project. 
10.4.  Total costs 
In table 16, the overall budget of the bachelor thesis is specified: 
Total costs 
Category Total (€) 
Labour costs 15920 
Sol-gel costs 40.5 
Ball-milling costs 156.2 
Characterization 2420 
 18536€ 
Table 19: Overall budget of the project. 
 




11. NORMATIVE AND LEGAL ASPECTS 
 
The experimental procedure, which includes all the process of synthesising and 
characterizing the hydroxyapatite, as well as the cytotoxicity assays has followed 
the normative and legal aspects described in Materials Science and Physical 
Chemistry Department at the University of Barcelona.  
Researchers and teachers working on the laboratory explained and defined a set 
of rules and obligations in order to protect the safety of all the members and of 
the laboratory worked. These standards are included in the laboratory's good 
practice manual. Wearing a gown and having the eyes protected with goggles, 
leaving the space clean, not pouring toxic products in inappropriate places, are 
an example of the obligations that must be followed to be able to conduct a correct 
and safe laboratory practice.  
Moreover, as the final product is expected to be commercialized as medical 
device, it is important to consider a rigorous and strict regulation.  
11.1. Medical device classification 
As medical devices are products with its aim is to save or help people’s life, a 
heavy regulation is needed. Its regulation is primarily concerned on enabling 
patient access to high quality, safe and effective medical devices, and avoiding 
access to products that are unsafe[51].  
The FDA establishes a medical device classification system with the aim of 
placing each device in a category according to its duration contact with the 
patient, the part of the body affected and the degree of invasiveness. This 
classification is established with the aim of providing a reasonable assurance of 
safety. The FDA, categorized medical devices into the regulatory classes: Class 
I, II and III. As the level of risk increases, a more safety control will be needed in 
order to commercialize the medical device [51], [52].  
As it is displayed in the Table 20, Class I-type devices are low risk and they are 
only subjected to general controls such as tests of sterility. Furthermore, Class II 
devices, require more specific controls such as additional labelling requirements. 
Finally, class III products, such as defibrillators, require clinical studies evaluating 
its effectiveness and safety. Those studies are called pre-market approval 
application [52]. 
Hydroxyapatite coatings are not a medical device itself, however, it will form part 
of a medical device, in this case, the implant. Therefore, as the coating of 
hydroxyapatite is an intrinsic part of the implant, it will be evaluated and classified 
as class II or class III, depending on the ending use of the implant. If is a dental 
implant, it will be considered as class II, however, knew or hip implants are 




Class Risk Examples Controls 
I Low Hospital Beds General controls 
II Medium Absorbable sutures General and special 
controls 
III High Implantable pacemaker, implanted 
prosthetics 
General and special 
controls, 
Pre- market authorization 
Table 20: Different classes of medical devices classified according to its risk. 
11.2. Regulations 
11.2.1 Good Laboratory Practice  
As it is explained before, as the major part of the bachelor thesis has been 
performed in the laboratory, a good laboratory practice has been followed. The 
good laboratory practice is concerned with the organisational process and the 
conditions under which non-clinical health and environmental safety studies are 
planned, performed, monitored, recorded, archived and reported. [53] This good 
laboratory practice has several principles. One of the main principals is to ensure 
that all the processes and machines are correctly and regularly checked. 
Moreover, all the accuracy of the machines must be ensured in order to have a 
good quality of results. However, the most important part to consider in this 
Bachelor thesis is all the set of protocols that must be followed when working on 
the laboratory. Some examples will be described  
For example, when the powders were milled, a specialized mask is required due 
to when the powder is been milled, a huge amount of nanoparticles are released 
into the air, which can affect the respiratory system. Therefore, it is very important 
to ensure a proper ventilation and avoid grinding with people around.  
Furthermore, when some toxic or volatiles reagents, such as triethyl phosphite, 
are handled, it is necessary to use fume cupboards.  
Finally, as the bachelor thesis includes cells assays and therefore, manipulation 
of biological material, some specific requirements must be followed.  
Cell cultures are the result of the "in vitro" growth of cells obtained from organisms 
multicellular. The Spanish Royal Decree, defines, in Article 2 of Royal Decree 
664/1997, cell cultures as biological agents. Cell cultures always must be handled 
in a class II biosafety cabinet. If any culture medium is spilled, is very important 





11.2.1 Hydroxyapatite and implant 
regulation 
In Spain, the regulation of medical devices is specified in the Royal Decree 
822/93. The final product must follow several ISO norms: 
-ISO 10993, a set of harmonized standards that address the biological evaluation 
of medical devices [52]. The purpose of this ISO norm is to test the 
biocompatibility of the device. Testing the biocompatibility of the implants is 
essential due to the final product is an implant device which will be in contact with 
tissues and bones. Several test, such as cytotoxicity or hemocompatibility, must 
be performed before introducing the device to human body.  
-ISO 14971: a set of harmonized standards that address the risk management of 
medical devices, including software and in vitro diagnostic medical devices. This 
norm intents to assist manufacturers of medical devices to identify 
the hazards associated with the medical device, to estimate and evaluate the 
associated risks, to control these risks, and to monitor the effectiveness of the 
controls [53]. 
-ISO 13485: represents all the necessary requirements for the quality system of 
medical devices. 
Moreover, as the major part of the performance of the project will take part on the 
laboratory, several ISO norms must be considered, like ISO 15189, that is 
exclusively designed for medical laboratories or ISO 15189 specifies particular 
requirements for quality and competence of medical laboratories 
Lastly, in order to sell any product freely in any part of the European Economic 
Area, the CE marking is needed. It is a certification mark that indicated 
conformity with health, safety and environmental protections standards of the 
EEA (European Economic Area). In order to get this quality marking, some steps 
must be followed. The assessment will be approved by an external entity. The 
European Union has its directive regarding active implantable medical devices, 
DIRECTIVE 90/385/EEC. Once the device has been granted a CE mark in one 
Member state, it can be marketed in all the other European Member States 







12. CONCLUSIONS AND FUTURE TRENDS 
 
This research aimed to synthetize Sr-Mg-Zn substituted hydroxyapatite powders 
with sol-gel and ball milled process. As main of this project: 
 Based on the characterization results, both techniques are suitable 
methods for obtaining of Sr, Mg and Zn- substituted hydroxyapatite 
powders with a homogeneous composition.  
 DRX spectrums showed that the optimal thermal treatment selected for 
sol-gel powder samples in order to obtain an appropriate hydroxyapatite 
phase was 600ºC for 1 hour.  
 DRX characterization proved that ionic substitution reduces the 
crystallinity of the samples in both ball-milling and sol-gel process. 
 Laser scattering results reflected that ball-milled samples showed 
smaller size particle than hydroxyapatite obtained by sol-gel method.  
 Substituted hydroxyapatite obtained by sol-gel methodology and 
ball-milling techniques do not show toxicity against Primary Human 
Osteoblasts following the methodology described by ISO 10993-5:2009. 
 The fluidity of ball-milled powder was not suitable for a correct 
deposition, even after steps of agglomeration process.  
Due to lack of time, many different experiments and studies have been left for the 
future. And as future recommendations: 
 A deep study and characterization of substituted hydroxyapatite samples 
with different molar ion concentration is needed in order to asses which 
percentage of concentration exhibits the optimal properties to the samples.  
 Is necessary to optimize the final particle size modification for sol-gel and 
ball-milled powders due to is the main cause of the plasma spray results 
failure. It is important optimize the agglomeration process to increase the 
particle size of ball-milled powder.  
 Is study whether the incorporation of different ions, such as silicon or iron 
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